Pure Primary Extragonadal Retroperitoneal Yolk Sac Tumour in a Young Child: A Case Report
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5
Abstract
Germ Cell Tumours (GCTs) in children are uncommon, constituting approximately only 3% of all malignancies in children younger than 15 years of age. Primary extragonadal GCTs constitute only 1-5% of all GCTs and a retroperitoneal site is seen only in 4% of all extragonadal GCTs. Extragonadal GCTs arise from local transformation of primordial germ cells which have been misplaced during the migration of these cells through the midline dorsal mesentery in the fourth-sixth week of embryogenesis. GCTs in children show remarkable variability in age, site, presentation and histology. This is the case of a three-year-old male child who presented with a history of an abdominal swelling which was rapidly progressive in nature. Radiology showed a large retroperitoneal mass and lesions in the liver. Histopathology, immunohistochemistry and serum Alpha-fetoprotein (AFP) values confirmed a diagnosis of pure primary extragonadal yolk sac tumour
Authors and Affiliations
Vineeth G Nair, HS Kiran, PR Shanthala
Keywords
Related Articles
- EP ID EP341992
- DOI 10.7860/JCDR/2017/24892.9781
- Views 53
- Downloads 0
Correspondence: Periodontal Health among Non-Hospitalized Chronic Psychiatric Patients in Mangaluru City-India
Letter to Editor
Clinical Score for Risk Stratification in Febrile Thrombocytopenia
ABSTRACT Introduction: The monsoon and peri-monsoon season often entail, a high patient influx with fever and thrombocytopenia. In severe cases, blood transfusion is necessary, but as there are no guidelines or a precise...
Modelling the Frequency of Depression using Holt-Winters Exponential Smoothing Method
ABSTRACT Introduction: Depression is a worldwide concern causing lots of adverse social consequences. Aim: To assess the stochastic processes of depression frequency through statistical modelling. Materials and Method...
Idiosyncratic Liver Injury due to Rivaroxaban
Rivaroxaban is an oral direct factor Xa inhibitor that has been used for the primary and secondary prophylaxis of thromboembolic disorders. Once daily dosing makes it an attractive alternative when compared to other Nove...
Dengue Vaccines: Current Status and Future Prospects
Editorial